Patients as Partners EU Overview in 3 Minutes

The 2nd annual Patients as Partners EU is the only conference in Europe that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. In this short podcast, Valerie Bowling, executive director at the Conference Forum gives a brief summary of what to expect at this conference and runs through the highlights.  Chairs: Tony Hoos, MD, PhD, MBA Head of Medical, Amgen Europe Andrew Garvey Global Patient Advocacy Lead, GlaxoSmithKline The premier event was attended by roughly 150 people and the program brings back: Accreditation by Patients Included “Ask the Patient” program to give attendees the opportunity to meet a group of individuals who’ve experienced a clinical trial.Attendee “Tool-Box” and an assortment of specially designed materials to help capture ideas. Patients as Partners EU is co-produced with industry, patient advocacy and government to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement across the entire clinical development continuum with the goal of driving greater efficienices. It is attended primarily by pharmaceutical operation and advocacy executives and patient advocacy trusts.  There is a small exhibit room with tons of networking.  January 23-24, 2018 Radisson Blu Portman Hotel, London, UK For more information visit www.theconferenceforum.org  Special rates for trusts and use code TEML for 10% off.